General
Preferred name
CEFUROXIME
Synonyms
Cefuroxime sodium salt ()
Anaptivan ()
Biociclin ()
CEFUROXIME SODIUM ()
Cefuroxime (sodium) ()
Cefuroxime ()
Britacef ()
Kefurox ()
Zinacef ()
Sodium cefuroxime ()
Cefuroximine ()
640/359 ()
Cefuroxime acid ()
Cefuroxime (sodium salt) ()
Cefuroxime-d3 ()
P&D ID
PD009800
CAS
55268-75-2
56238-63-2
153012-39-6
1803240-98-3
Tags
natural product
drug
available
Approved by
FDA
First approval
1983
Drug Status
approved
Drug indication
Antibacterial
Acute bronchitis
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cefuroxime is a semisynthetic, second-generation cephalosporin antibacterial. It has broad-spectrum activity and is β-lactamase-resistant. Oral formulations contain the prodrug cefuroxime axetil. (GtoPdb)
Compound Sets
20
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
61
Properties
(calculated by RDKit )
Molecular Weight
424.07
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
1
cLogP
-0.54
TPSA
173.76
Fraction CSP3
0.31
Chiral centers
2.0
Largest ring
6.0
QED
0.3
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Microbiology&virology
Anti-infection
Target
antibiotic
Bacterial
Beta-lactamase
¦Â-Lactamase
MOA
Antibiotic
bacterial cell wall synthesis inhibitor
Indication
gram-negative bacterial infections
Therapeutic Class
Antibiotics
Source data